|
T.SVA
|
Also, towards the end of 2022, look for updates on progress towards a new...
|
|
T.SVA
|
Sernova has one patient in their clinical study that has been insulin...
|
|
T.SVA
|
Yes. I liked Dr. T's final comment after the interviewer suggested they...
|
|
T.SVA
|
I am just a fresh-faced newbie here. Biotech and MetalsGuy made me feel so...
|
|
T.SVA
|
Bio, on Post# 34324887 you mentioned how many shares you have. I wouldn&...
|
|
T.SVA
|
Investing in biotechs is a very risky business. The reason investors do it is...
|
|
T.SVA
|
Indeed! Recent updates on the whole trifecta: Diabetes T1D, Severe Hemophilia...
|
|
T.SVA
|
Thanks for the vote of confidence, MetalsGuy. You continue to prove what a...
|
|
T.SVA
|
All good points, Sailboat. And I agree that Philip appears to be the wrong...
|
|
T.SVA
|
Ok, so you do not believe Dr. T is the right person in charge at this point...
|
|
T.SVA
|
Nobody is stopping you from moving on, Bio. Find a management you like. Or...
|
|
T.SVA
|
The gutters are lined with investors who lacked patience. There is some luck...
|
|
T.SVA
|
For those who don't know, JDRF Canada is the largest ...
|
|
T.SVA
|
Pouch: No fibrosis; donor cells work for two T1D patients so far Cell...
|
|
T.SVA
|
MetalsGuy: Just keep me on ignore and quit peeking. Jeez...
|
|
T.SVA
|
Nope, that was you. I am just adding on big down days. You got any dry powder...
|
|
T.SVA
|
The measure of a man is how he handles adversity. MetalsGuy is having a...
|
|
T.SVA
|
Good point, Mercury. But to further clarify, Sernova's January 10 news...
|
|
T.SVA
|
Sernova Announces Peer Reviewed Publication Demonstrating Safety and Efficacy...
|
|
T.SVA
|
According to InkResearch, there has been no insider buying in the last twelve...
|